ORKA vs XOM · $4.27B cap vs P/E 24, rev $201.16B
Oruka Therapeutics, Inc. (ORKA) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE.
ORKA does not have a complete income-statement cache yet.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
ORKA currently screens at market cap $4.27B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the ORKA and XOM stock pages for the full models.
Not investment advice.